<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="UTF-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=edge" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />

    <!----======== CSS ======== -->
    <link rel="stylesheet" href="../styles/interventions_pages.css" />
    <link rel="stylesheet" href="../styles/nav.css" />
    
    <!----======== JS ======== -->
    <script src="../js/plot_overview.js"></script> 

    <link
      rel="stylesheet"
      href="https://fonts.googleapis.com/css2?family=Material+Symbols+Outlined:opsz,wght,FILL,GRAD@48,400,0,0"
    />
    <link rel="icon" href="../img/profile_icon_inter.svg" />
    <link
      rel="stylesheet"
      href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.14.0/css/all.min.css"
    />
    <script src="https://cdnjs.cloudflare.com/ajax/libs/animejs/3.2.1/anime.min.js"></script>
    <script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>
    <script src="https://code.jquery.com/ui/1.13.1/jquery-ui.min.js"></script>
    <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
  </head>
  <body><div class='desc_tab'>More information about<br>N-acetylcysteine (NAC)</div><div class="btn_container"><a href="interventions.html" class="button"
                ><i class="far fa-arrow-alt-circle-left fa-2x"></i>Back to other
                interventions</a
                ></div><div class='hero'><div class='hero_image'><img src='https://cdn.pixabay.com/photo/2015/08/02/23/14/acetylcholine-872247_1280.png' /></div><div class='hero_left'><div class='hero_history'></div><div class='hero_description'><div class='header_tab'>Description of N-acetylcysteine</div><p>N-acetylcysteine (NAC) is a derivative of the amino acid cysteine and serves as a precursor to glutathione, one of the body’s most essential antioxidants. Glutathione plays a critical role in protecting cells from oxidative stress and maintaining overall cellular health. Due to its powerful antioxidant properties and its ability to modulate the glutamatergic and dopaminergic systems, NAC has been explored as a therapeutic option for various psychiatric and neurological conditions.</p></div></div></div><hr class="custom-hr"><div class='header_shalf'>Main features of N-acetylcysteine</div><div class='shalf'><div class='shalf_carac'><div class='card_carac_container'><div class='card_caracteristic'><div class='card_caracteristic_head'>Users of NAC</div><div class='card_caracteristic_img'><div class='ul_age'><div class='child'></div></div></div><div class='card_caracteristic_body'>The intervention is typically designed for School-age children (6-12 yo), with <b>important cognitive difficulties</b>. </div></div><div class='card_caracteristic'><div class='card_caracteristic_head'>Implementation</div><div class='card_caracteristic_img'><div class='ul_age'><div class='homeT'></div></div></div><div class='card_caracteristic_body'>This type of intervention is delivered <b>at home</b>. It is typically administered by <b>professionals</b>. </div></div><div class='card_caracteristic'><div class='card_caracteristic_head'>Duration and dosage</div><div class='card_caracteristic_img'><div class='ul_age'><div class='medium'></div></div></div><div class='card_caracteristic_body'>On average this type of intervention lasts about <b>3 months</b> (from 2 months to 6 months), for an average of <b>1186 mg/day</b> (from 500 mg/day</b> to 1800 mg/day). </div></div></div></div><hr class="custom-hr"><div class='header_shalf'>Evidence about efficacy and safety of<br> N-acetylcysteine</div><div class="container_canvas"><canvas id="myScatterPlot"></canvas></div><hr class="custom-hr"><div class='bottom_ressources'><div class='header_shalf'>Additional resources</div><div class='header_tab'>Links to identified meta-analyses for NAC</div><div class='ressources'><ul class='hrztl_list'><li> <a href='https://doi.org/10.1016/j.pnpbp.2021.110476' target='_blank'>Liu (2022)</a></li><li> <a href='https://doi.org/10.1177/0004867420952540' target='_blank'>Lee (2020)</a></li><li> <a href='https://doi.org/10.1186/s13229-022-00488-4' target='_blank'>Siafis (child) (2022)</a></li><li> <a href='https://doi.org/10.1002/14651858.CD011769.pub2' target='_blank'>Iffland (2023)</a></li><li> <a href='https://doi.org/10.1016/j.jaac.2020.03.007' target='_blank'>Zhou (2021)</a></li></ul></div><br><div class='header_tab'>Additional ressources</div><div class='ressources'><ul><li><a href='https://link.springer.com/article/10.1007/s40263-022-00907-3' target='_blank'>Bradlow, R.C.J., Berk, M., Kalivas, P.W. et al. The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders. CNS Drugs 36, 451–482 (2022). https://doi.org/10.1007/s40263-022-00907-3</li></a><ul></div></div><script>createScatterPlot('../js/NAC.json');</script></body>
  </html>
